AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
BioHarvest Sciences Inc.
Video analysis: BHST
All videosNo video analysis for this stock yet. Request one from our team.
News: BHST
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 14, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14-16, 2026, in New York City, NY.
Fiinu shares jump over 6% as Conister Bank platform enters production
Fiinu (AIM: BANK), the UK fintech group, rose over 6% to 4p on Friday after its Plugin Overdraft platform moved into production ahead of a planned year-end...
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) plans to pursue a dual listing of its ordinary shares on the Tel Aviv Stock Exchange (TASE), with trading expected to begin on September 8, 2026. The company, which is listed on the Nasdaq Capital Market, expects the TASE listing to provide investors in Israel with access to its shares.
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the TASE on September 8, 2026.
BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
BioHarvest Sciences Q2 Earnings Call Highlights
BioHarvest Sciences NASDAQ: BHST reported second-quarter 2026 revenue of $8.8 million, up 3.8% from $8.5 million a year earlier, while highlighting its first manufacturing and supply agreement within its contract development and manufacturing organization, or CDMO, business.
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) reported higher second-quarter revenue as the plant-based molecule developer shifted spending toward manufacturing capacity. Revenue for the quarter was $8.8 million, up 3.8% from a year earlier.
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.15 per share a year ago.
Similar companies
-
American Vanguard Corporation
AVD
·
New York Stock Exchange
Compare
-
Bioceres Crop Solutions Corp.
BIOX
·
NASDAQ
Compare
-
Friedman Industries, Incorporated
FRD
·
NASDAQ
Compare
-
U.S. GoldMining Inc.
USGO
·
NASDAQ
Compare
-
FutureFuel Corp.
FF
·
New York Stock Exchange
Compare
-
Core Molding Technologies, Inc.
CMT
·
New York Stock Exchange Arca
Compare